Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 9, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

Computational chemistry at Janssen.

Herman van Vlijmen¹, Renee L Desjarlais², Tara Mirzadegan³

¹Discovery Sciences, Janssen Research and Development, Beerse, Belgium. hvvlijme@its.jnj.com.

Journal of Computer-Aided Molecular Design

|December 21, 2016

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combining Bayesian and Evidential Uncertainty Quantification for Improved Bioactivity Modeling.

Journal of chemical information and modeling·2025

Same author

A Novel Small Molecule Allosteric Inhibitor of IL-17A from a DNA-Encoded Library.

ACS medicinal chemistry letters·2025

Same author

A New Fragment-Based Pharmacophore Virtual Screening Workflow Identifies Potent Inhibitors of SARS-CoV-2 NSP13 Helicase.

Journal of computational chemistry·2025

Same author

Identification of an Induced Orthosteric Pocket in IL-23: A New Avenue for Non-biological Therapeutic Targeting.

ACS chemical biology·2025

Same author

Discovery of a non-nucleoside inhibitor that binds to a novel site in the palm domain of the respiratory syncytial virus RNA-dependent RNA polymerase.

Journal of virology·2025

Same author

A Patient-Derived 3D Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates.

Clinical and translational science·2025

Same journal

RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis.

Journal of computer-aided molecular design·2026

Same journal

Integrating evolutionary and compositional features with ML and DL for robust and interpretable druggable protein prediction.

Journal of computer-aided molecular design·2026

Same journal

QUAD: a composite risk framework integrating uncertainty, applicability domain, and model disagreement for reliable QSAR predictions.

Journal of computer-aided molecular design·2026

Same journal

Comparative quantum-chemical investigation of 2-chloro-N-(4-methoxyphenyl)acetamide and 2-(4-methoxyphenylamino)-2-oxoethyl meth/acrylate: DFT, TD-DFT, and non-covalent interaction analyses.

Journal of computer-aided molecular design·2026

Same journal

Discovery of a novel CaMKⅡα inhibitor by machine learning, molecular docking and molecular dynamics simulation.

Journal of computer-aided molecular design·2026

Same journal

Explainable QSAR models of 5-HT1A receptor ligands using conceptual DFT descriptors and no-code machine learning tools.

Journal of computer-aided molecular design·2026

See all related articles

Janssen

Area of Science:

Computational Chemistry
Drug Discovery Sciences

Background:

Overview of computational chemistry group within Janssen Discovery Sciences.
Focus on organizational and operational structure.

Purpose of the Study:

To provide a comprehensive perspective on the Computational Chemistry group's role.
To highlight the group's contributions to drug discovery at Janssen.

Main Methods:

Review of organizational structure.
Analysis of scientific approaches.
Examination of collaboration strategies.

Main Results:

Detailed insight into the group's operational framework.
Understanding of the scientific methodologies employed.

Keywords:

Computational chemistry Computer aided drug design Drug discovery

More Related Videos

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

Related Experiment Videos

Last Updated: Mar 9, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

Evidence of successful internal and external collaborations.

Conclusions:

The Computational Chemistry group is integral to Janssen's drug discovery.
Effective structure and collaborations drive scientific impact.
The group significantly influences the drug discovery pipeline at Janssen.